Table 1.
Baseline characteristics of women by study group.
| Group | |||
|---|---|---|---|
| Measurements | Placebo (n=19) | Inulin (n=19) | p |
| Age (years) | 51.89 (10.36) | 51.58 (8.45) | 0.919 |
| Weight (kg) | 61.97 (10.90) | 69.16 (13.77) | 0.083 |
| Fasting glucose | |||
| Normal | 11 (28.9) | 4 (10.5) | 0.045 |
| High | 8 (21.1) | 15 (39.5) | |
| Creatinine clearance | |||
| Low | 8 (21.1) | 7 (18.4) | 0.999 |
| Normal | 11 (28.9) | 12 (31.6) | |
| Menopause | |||
| Premenopause | 9 (23.7) | 7 (18.4) | 0.743 |
| Postmenopause | 10 (26.3) | 12 (31.6) | |
| Chronic medication | |||
| Yes | 7 (18.4) | 12 (31.6) | 0.194 |
| No | 12 (31.6) | 7 (18.4) | |
| HTA medication | |||
| Yes | 4 (10.5) | 10 (26.3) | 0.091 |
| No | 15 (39.5) | 9 (23.7) | |
Data: media (standard deviation); Student's t-test: ∗p<0.05.
n (%), χ2 test: ∗p<0.05.
Fasting glucose: normal ≤99 mg/dl; high ≥100 mg/dl.
Creatinine clearance: normal ≥90 ml/min; low ≤89 ml/min.
HTA: hypertension.